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The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a northern Han Chinese 
Introduction
Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system (CNS) and a common cause of neurological disability in young adults (Compston and Coles, 2008) . The prevalence of MS in Asia is lower than that in the Western countries. Although the precise etiology o f the disease remains unknown, a genetic predisposition as well as environmental factors are generally considered to be involved in the pathogenesis of MS (Ascherio, 2013; Xie et al., 2015) . In the past few years, genome-wide association studies (GWASs) of MS have demonstrated that the human leukocyte antigen (HLA) is the major locus of MS susceptibility; these studies have also provided unequivocal evidence for the association between 110 additional non-HLA candidate genetic variants and susceptibility to the disease (International Multiple Sclerosis Genetics et al., 2013; International Multiple Sclerosis Genetics et al., 2007; Patsopoulos et al., 2011) .
Neuromyelitis optica spectrum disorder (NMOSD) is an idiopathic inflammatory disease of the CNS primarily affecting the optic nerves and the spinal cord (Han et al., 2017; Jarius et al., 2014; Wingerchuk et al., 2007) . NMOSD has been distinguished from MS following the discovery of an autoantibody that targets aquaporin 4 (AQP4-IgG) (Lennon et al., 2004) . The prevalence of NMOSD in the general population ranges from 0.0003% to 0.0044% (Cabrera-Gomez et al., 2009) , with some J o u r n a l P r e -p r o o f regional and racial differences compared to the occurrence of MS (Wingerchuk et al., 2007) . NMOSD is relatively common in non-white populations, particularly in East Asia (Kira, 2008; Wingerchuk et al., 2015) . As in MS, genetic and environmental risk factors contribute to the occurrence and development of NMOSD. In previous genetic studies, the frequency of HLA genes such as HLA-DPB1*0501 (Wang et al., 2011) , Blanco et al., 2011) , and HLA-DRB1*03 (Brum et al., 2010; Deschamps et al., 2011) correlated with the risk of NMOSD. In non-HLA genetic study series, risk polymorphisms such as CD6 TNFRSFIA (Park et al., 2013) , CD58 (Kim et al., 2014) , AQP4 (Ogasawara et al., 2016; Park et al., 2014) , CYP7A1 (Kim et al., 2010; Zhao et al., 2013; Zhuang et al., 2015) , IL17 (Wang et al., 2012) , IL2RA (Ainiding et al., 2014; Dai et al., 2013) , ATG5 (Cai et al., 2014) , and FCRL3 (Wang et al., 2016) were found to confer susceptibility to NMOSD. However, compared to MS, there have been fewer studies on only the genetics of NMOSD.
GTF2I encodes the transcription factor II-I (TFII-I), and is located closely on chromosome 7 of humans. TFII-I exhibits the α, β, γ, and δ alternatively spliced isoforms in humans. As a signal induced transcription factor, TFII-I plays a crucial role in the transcriptional regulation of the vascular endothelial growth factor receptor-2 (VEGFR2), and participates in the regulation of triggering of the B cell receptor and T cell receptor (Roy, 2017) . Previous studies have suggested that the gene copy number variations are implicated in Williams-Beuren syndrome (Enkhmandakh et al., 2009;  J o u r n a l P r e -p r o o f Sanders et al., 2011) and 7q microduplication syndrome (7dupASD; ASD, autism spectrum disorder) (Sanders et al., 2011) . Several recent GWASs have revealed that GTF2I rs117026326 is involved in three autoimmune diseases: primary Sjögren's syndrome (pSS) (Li et al., 2013) , systemic lupus erythematosus(SLE) (Sun et al., 2016) in a Chinese Han population, and rheumatoid arthritis(RA) (Kim et al., 2016) and GTF2IRD1 in each sample was determined using real-time quantitative reverse transcription PCR and was normalized to the GAPDH control.
Statistical analysis
The Hardy-Weinberg equilibrium was initially determined. and 95% confidence intervals (CI) were calculated. A P-value of less than 0.05 was considered statistically significant.
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Results

Single nucleotide rs117026326 polymorphism is associated with NMOSD
The characteristics of the 144 patients and 1403 independent controls included in this study are shown in Table 1 . All patients and control subjects in the analysis are self-reported Han Chinese. As shown in Table 2 and Table 3 , the T allele frequency of rs117026326 in patients with NMOSD (T = 36%) was significantly higher than in patients with MS (T = 18%) and controls (T = 18%). A single-marker association was performed using logistic regression. We observed a significant association between variant rs117026326 and NMOSD (P = 1.09×10 -11 , OR = 2.535) in our cohort. The results demonstrate a significant association between the genetic variant at the GTF2I locus and NMOSD in Chinese Han patients and suggest an important role of the GTF2I locus in the pathogenesis of NMOSD. The T allele of rs117026326 increases risk for NMOSD. In order to find the associations between the T allele of rs117026326
and clinical characteristics of NMOSD, we further explored the relationship of the T allele of rs117026326 with Expanded Disability Status Scale (EDSS) scores and Annual Recurrence Rate (ARR) in NMOSD using one-way analysis of variance (ANOVA). Our results (P EDSS =0.4203, P ARR =0.6314) showed that the T allele of rs117026326 had no significant correlation with the EDSS scores and ARR (see Figure   2 and Figure 3 ). Further functional studies are needed for a better understanding of the underlying molecular mechanisms.
The rs117026326 variant does not affect the risk for MS
To assess whether the rs117026326 variant carries a risk for MS, we genotyped the variant in 168 patients with MS and matched population controls. Further assessments of allele frequencies of the variants in patients with MS and control subjects revealed that the minor allele frequency of the variant was 18% in patients with MS and 18% in controls (Table 3) . A genetic association test, adjusted for age and gender, was performed using logistic regression with multiple models. We did not detect a significant association between the variant and MS (P = 0.4289, OR = 1.129).
Genetic variant rs117026326 does not influence mRNA expression of GTF2I and neighboring genes GTF2IRD1 in PBMCs from patients
Previous studies showed no significant associations between the genotypes of the variant rs117026326 and GTF2I expression in Sjögren's syndrome, SLE, and RA. To evaluate the expression level of GTF2I and the neighboring genes, GTF2IRD1, we determined the expression of GTF2I and GTF2IRD1 in circulating leucocytes of 16 patients with MS and 17 patients with NMOSD. In line with published gene expression data, we did not detect correlations between the genotypes of the variant and mRNA expression of the GTF2I and GTF2IRD1 genes (see Figure 1 ).
Discussion
The first GWAS for pSS in Han Chinese recently reported that the GTF2I rs117026326 C/T polymorphism is the locus indicating the strongest susceptibility to the disease, with the T allele being the risk allele (P = 1.31×10 -53 , OR 2.20) for pSS (Li et al., 2013) . Since SLE and pSS have a close clinical relationship and a shared pathophysiology, further studies have been carried out. Celi Sun and his colleagues confirmed that GTF2I rs733666469 polymorphism increases the risk of SLE in a study in six East Asian cohorts with 4478 SLE cases and 12656 controls (Sun et al., 2016) . A later study confirmed that the GTF2I polymorphism is associated with the pathogenesis of RA in Asian cohorts (Kim et al., 2016) . Another replication study in
Chinese patients with pSS showed that this polymorphism is associated only with anti-SSA-positive but not anti-SSA-negative pSS (Zheng et al., 2015) . In the current study, we found that the frequency of the risk T allele of GTF2I rs117026326 was significantly increased in patients with NMOSD, but not in those with MS.
TFII-I encoded by GTF2I is an essential gene in mice, and it has been reported to be involved in the regulation of T and B cell activation by deregulation of VEGFR2 gene in previous studies (Makeyev and Bayarsaihan, 2009; Ren et al., 2011; Roy, 2017) .
TFII-I controls B cell proliferation via regulating NF-κB, although the precise mechanism underlying these processes is not clear (Ashworth and Roy, 2007) .
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Dysregulation of B cells may affect NMOSD disease activity via antigen presentation, proinflammatory and anti-inflammatory cytokine production, and immunoglobulin production. Potential mechanisms include the expansion of AQP4-specific plasmablast clones, failure to eliminate autoreactive B cell subsets, insufficient antigen-specific regulatory B cells, and/or the loss of anergic maintenance (Bennett et al., 2015; Fan et al., 2016) . In this study, we found that the rs117026326 polymorphism is associated with NMOSD; however, the mechanism remains unclear and needs to be elucidated in future studies. EDSS scores represent the severity of NMOSD, and ARR can be used as a disease feature to evaluate disease status. Our results showed that the T allele of rs117026326 had no significant correlation with EDSS scores or ARR. It could be related with a small number of case samples. And more clinical characteristics of patients like total disease duration and spinal cord lesion segments should be considered.
While the small number of case samples is one limitation of our study, we intentionally only recruited patients whose diagnoses were clear, to avoid case ascertainment errors.
In conclusion, our results show that the GTF2I rs117026326 polymorphism is associated with NMOSD in Han Chinese, but not with MS. Our findings shed new J o u r n a l P r e -p r o o f 
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